The pathways by which islet B, A, and D cells bind and internalize homologous (self) and heterologous (other) islet hormones were compared. I'25I-TyrjSomatostatin-14 (S-14), 1251-insulin, and 1251-glucagon were incubated with monolayer cultures of neonatal rat islet cells. Tissues were processed for quantitative electron microscopic autoradiography by the probability circle method coupled to morphometry. For all three radioligands and all three cell types surface labeling was rapidly followed by internalization of the radioligands into endocytotic vesicles. The further intracellular movement of the ligand occurred in a time-and temperature-related manner and depended on whether it was homologous or heterologous for the cell in question. We conclude that (a) each of the three radioligands is internalized by islet cells in a time-and temperature-dependent manner; (b) after initial internalization the further intracellular progression of the endocytosed radioligand occurs freely in cells heterologous for the radioligand but poorly in cells homologous for the radioligand; and (c) binding and endocytosis can be uncoupled from lysosomal degradation of ligand.
Introduction
Receptor-mediated endocytosis is a general process through which polypeptide hormones and other agents that bind to high affinity sites on cell surfaces are internalized (1) (2) (3) . The intracellular path of the ligand-receptor complex follows a fairly typical route which involves initial binding of the ligand to the plasma membrane, aggregation of the ligand-receptor complexes around coated pits, the internalization of the complexes via endocytotic vesicles, and the transport and fusion of these vesicles with primary lysosomes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In the resulting secondary lysosomes the complexes undergo dissociation, the ligand is degraded, and the receptor is freed for recycling to the Receivedforpublication 6 June 1988 and in revisedform 15 March 1989. plasma membrane. Internalization occurs rapidly and is a time-and temperature-dependent process (3) (4) (5) (6) (7) (8) (9) (10) .
Specific, high-affinity binding sites for somatostatin (16) (17) (18) , insulin (17, 19) , and glucagon (17, 20, 21) have been demonstrated on normal whole islets (16, 19) , purified islet B cells (21) , and neoplastic islet cells (17, 18) by direct binding assays. Using the technique of quantitative electron microscopic autoradiography, we have previously identified specific binding sites for radioiodinated somatostatin-14 (S-14), '1251-insulin, and '251-glucagon on neonatal islet B, A, and D cells in monolayer culture (22, 23) . We have extended these observations and now describe the internalization of each radioligand by the three islet cell types.
Methods
Islet cell cultures and labeling experiments. Monolayer cultures of dispersed islet cells from 3-d-old rats were established in plastic Petri dishes as previously described (22, 23) . The medium consisted of MEM with 10% heat-inactivated FCS. The glucose concentration was maintained at 16.5 mM until day 5 of culture when it was reduced to 5.5 mM for 1 d before the labeling experiments which were conducted on day 6. Under these conditions islet cells grew in monolayer clusters rich in A, B, and D cells (24) . Petri dishes contained on an average -30-40 clusters, each containing 60-108 islet cells. Porcine monocomponent insulin (Novo Industrie, Copenhagen, Denmark), porcine glucagon (Novo Industrie), and synthetic tyrosinyl-somatostatin (Tyr-S-14; Bachem Fine Chemicals, Torrance, CA), were radioiodinated by the chloramine-T technique as previously reported (22, 25) . The specific activities of the three radioligands were 499 Ci/mmol '251-insulin, 1,365 Ci/mmol '25I-glucagon, and 1,355 Ci/mmol ['25I-Tyr]S-14.
Before commencement of the labeling experiments the maintenance media were discarded and the cells washed with 2 ml MEM-FCS. Paired Petri dishes were then incubated at 15 or 37°C for 5 or 60 min with 1 ml of medium (MEM-FCS, 5.5 mM glucose) containing radioiodinated hormones at the following concentrations: '25I-insulin, 5 for '25I-glucagon. All determinations were carried out on positive prints enlarged to a final magnification of 39,000. To estimate the binding of the three radioligands to the islet cells, all autoradiographic grains (ARG) present in a given cluster were photographed. The distance between the center of each grain and the surrounding membranes was then measured and expressed as halfdistances. In the event that an ARG in the intracellular space was exactly equidistant between the different types of cells, we gave half a chance to each cell to be related to the ARG. The halfdistance was assumed to be 900 A and we could then apply the universal curve for 125I-radiation. The grain distribution was calculated according to the method of Salpeter and Bachmann (27). We considered grains located within 250 nm of the plasma membrane as noninternalized (10) , those located beyond the 250-nm line as internalized. Results were expressed as percent of internalized grains over total grain number.
To estimate the probability that the radiation source lies within a given tissue compartment of the endocrine cells, we applied to the same pictures as the halfdistances, the 95% probability circle (Whur et al.) (28) coupled to the morphometric analysis of the size of the compartment by the point counting method (29) . This method corrects for the overlap ofa single developed grain with several different structures. The following compartments were considered: cell membrane, microvilli, endocytotic vesicles, lysosomes, multivesicular bodies, Golgi apparatus, secretory granules, and nucleus. We applied the formula Rvi+ = Gi/Pi (5 -d2 * T), where Rvi+ = specific radiation label density, Gi = number of points of the 95% probability circle falling on a compartment i, Pi = number of points of the morphometrical lattice falling on a compartment i, d = the point spacing of the lattice, and T = the section thickness. Data are expressed as Rvi+, which represents the number of grains per MM3 of a given compartment (i).
Results
Labeling ofislet cells. Autoradiographic grains associated with each radioligand were localized over B, A, and D cells, the three major islet cell types found in this system. The grains were distributed over the plasma membrane as well as intracellularly. The grains were specific and were virtually eliminated when ligands were coincubated with their corresponding unlabeled hormones in excess. The percent ofislet cells labeled with each radioligand at 37°C has been previously described (22) . In general, there was a time-and temperature-dependent increase in the labeling density Significant accumulation of '25I-insulin-related ARG was seen over plasma membranes, microvilli, and endocytotic vesicles of B, A, and D cells (Fig. 3) Whether grains localized on other specialized regions of the plasma membrane such as coated invaginations, previously described for 251I-insulin (10) but not for '251-glucagon binding (9), was not investigated in the present study. After initial binding the radioligands were rapidly internalized in a timeand temperature-dependent fashion and became progressively associated with vesicular structures: endocytotic vesicles, multivesicular bodies, lysosomes, and Golgi structures. The intracellular pathway for the three radioligands in the islet cells was thus in general similar to that resulting from receptor-mediated endocytosis reported for LDL and epidermal growth factor in cultured human fibroblasts (5, 43) , insulin in lymphocytes, hepatocytes, and adipocytes (4, 6-8, 10, 12), glucagon in hepatocytes (9), human growth hormone in lymphocytes (42) , and gonadotropin-releasing hormone ( 15) , corticotrophin-releasing hormone (44) , and somatostatin (13, 14) (4, 6-8, 10, 12) . Likewise, the internalization of glucagon by hepatocytes and peripheral leukocytes has been fully characterized (9, 45) . This, however, is the first report of the internalization of either radioligand by islet cells, with findings very similar to those reported for other target systems except for (a) the poor intracellular processing of both ligands in islet cells homologous for the ligand, and (b) a more rapid rate of internalization of 12511 glucagon in B and D cells compared with hepatocytes (9) . The internalization of somatostatin has been studied only in the anterior pituitary using as markers radioiodinated tyrosinated analogue of S-28 or gold-conjugated S-14 (13, 14) . The (14, 46) , no evidence for this was found in the present study. Finally, our demonstration ofrapid intracellular translocation of plasma membrane receptorbound ['251I-Tyr]S-14 in normal islet cells differs markedly from the behaviour of [251I-Tyr' ']S-14 bound to surface receptors on RIN m5F insulin-producing tumor cells which have been reported to process receptor-bound ligand through degradation in situ by surface-bound enzymes, rather than through internalization by receptor-mediated endocytosis followed by lysosomal degradation (47, 48) .
To our knowledge this is the first time that internalization of a hormone by a cell that normally secretes it has been described in detail. Our results show a dissociation between binding and internalization on the one hand, and subsequent lysosomal degradation of the internalized ligand on the other. Thus, the plasma membrane binding of ['25I-Tyr]S-14, '251-insulin, and '25I-glucagon to D, B, and A cells, respectively, was coupled to rapid internalization and the appearance of the ligands in endocytotic vesicles. The subsequent transfer of the radioactivity to lysosomal structures, however, appeared to be inhibited in each of the three cells. These data clearly illustrate that binding and endocytosis can be uncoupled from lysosomal degradation of ligand in islet cells and perhaps all secretory cells that internalize their own (homologous) radioligand. Occasional exceptions to this general rule were observed, probably due to methodological variations, although alternative explanations cannot be excluded. The process through which endocytotic vesicles are directed towards lysosomes is poorly understood but is believed to involve the juxtaposition of endocytotic vesicles and lysosomes during movement of the organelle through the cytoplasm followed by fusion of the membranes of the two structures (49) . This step appears to be rate limiting and can be selectively inhibited by perturbations such as low temperature (50) . Furthermore, substances within the endocytotic vesicle or the lysosome have been shown to inhibit fusion (49 
